HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Potential value of lncRNAs as a biomarker for proliferative diabetic retinopathy.

AbstractOBJECTIVES:
To investigate the differences in lncRNAs expression in whole blood between diabetic retinopathy (DR) patients and healthy subjects, and to evaluate the potential value of lncRNAs as a diagnostic biomarker for proliferative diabetic retinopathy (PDR).
METHODS:
A series of 34 PDR patients, 34 patients with non-proliferative DR (NPDR) and 34 healthy participants were enroled. Differentially expressed lncRNAs were demonstrated using high-throughput sequencing and validated using qRT-PCR. Gene Ontology (GO) was performed to explore the possible biological function of the differentially expressed lncRNAs. lncRNA/mRNA coexpression network was built to determine the targets of differentially expressed lncRNAs. Receiver operating characteristic (ROC) analysis was utilized to evaluate the diagnostic value of lncRNAs for PDR.
RESULTS:
We identified 175 and 179 differentially expressed lncRNAs in PDR patients compared with control samples and NPDR patients, respectively. GO analysis showed that the various metabolic processes were possibly influenced by these dysregulated lncRNAs. Using the differently expressed lncRNAs data, we further identified 82 overlapping lncRNAs in PDR patients with NPDR and control subjects. Part of these overlapping lncRNAs was significantly correlated with nuclear factor kappa B (NF-κB) and Wnt signal pathways. ROC curves were constructed for two upregulated lncRNAs and the ROC analysis indicated that both of them had potential diagnostic value and could distinguish PDR from control subjects and NPDR patients.
CONCLUSIONS:
LncRNAs expression was altered in PDR patients compared with NPDR and control subjects. Moreover, it provides a resource that lncRNAs might be novel diagnostic and prognostic biomarker for PDR.
AuthorsBing Liu, Chenyang Cong, Yan Ma, Xiaohua Ma, Han Zhang, Jiawei Wang
JournalEye (London, England) (Eye (Lond)) Vol. 36 Issue 3 Pg. 575-584 (03 2022) ISSN: 1476-5454 [Electronic] England
PMID33767408 (Publication Type: Journal Article)
Copyright© 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.
Chemical References
  • Biomarkers
  • RNA, Long Noncoding
  • RNA, Messenger
Topics
  • Biomarkers
  • Diabetes Mellitus
  • Diabetic Retinopathy (diagnosis, genetics)
  • Humans
  • RNA, Long Noncoding (genetics)
  • RNA, Messenger (genetics)
  • ROC Curve

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: